Reilley, Matthew J.
McCoon, Patricia
Cook, Carl
Lyne, Paul
Kurzrock, Razelle
Kim, Youngsoo
Woessner, Richard
Younes, Anas
Nemunaitis, John
Fowler, Nathan
Curran, Michael
Liu, Qinying
Zhou, Tianyuan
Schmidt, Joanna
Jo, Minji
Lee, Samantha J.
Yamashita, Mason
Hughes, Steven G.
Fayad, Luis
Piha-Paul, Sarina
Nadella, Murali V. P.
Xiao, Xiaokun
Hsu, Jeff
Revenko, Alexey
Monia, Brett P.
MacLeod, A. Robert
Hong, David S.
Article History
Received: 12 July 2018
Accepted: 28 October 2018
First Online: 16 November 2018
Ethics approval and consent to participate
: This study was reviewed and approved by the Institutional Review Board at the University of Texas MD Anderson Cancer Center. Written informed consent was obtained from the patients prior to treatment.
: Written informed consent was obtained from the patients for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors and is available for review by the Editor-in-Chief.
: PM, CC, PL, RW, and MVPN are employees of Astrazeneca. YK, TZ, JS, MJ, SJL, MY, SGH, XX, JH, AR, BPM, and ARM are employees of Ionis Pharmaceuticals. The remaining authors declare no potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.